Showing 271-280 of 3001 results for "".
Therapeutics Q&A
https://practicalneurology.com/columns/practice-management/therapeutics-qa/30767/Botulinum Toxin for Urinary IncontinenceNews
https://practicalneurology.com/archives/2015-june/news/30548/Epilepsy: Now and in the Future
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-now-and-in-the-future/30723/New drugs continue to offer hope to patients, as research seeks other ways to optimize care.A Banner Year in Headache Medicine
https://practicalneurology.com/diseases-diagnoses/headache-pain/a-banner-year-in-headache-medicine/30270/News
https://practicalneurology.com/columns/practice-management/news/30633/News
https://practicalneurology.com/columns/practice-management/news/30565/Expert Opinion: Male Opioid-Induced Hypogonadism in the Management of Chronic Pain
https://practicalneurology.com/diseases-diagnoses/headache-pain/expert-opinion-male-opioid-induced-hypogonadism-in-the-management-of-chronic-pain/30753/Patients on long-term opioid therapy should be actively monitored for signs and symptoms consistent with hypogonadism.Overview of Adult Onset Cerebellar Ataxia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/overview-of-adult-onset-cerebellar-ataxia/30737/Benefits of PFO Closure Confirmed in Publication of Trial Data
https://practicalneurology.com/diseases-diagnoses/stroke/benefits-of-pfo-closure-confirmed-in-publication-of-trial-data/30310/POINT-COUNTERPOINT: Natalizumab Extended-Interval Dosing
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/point-counterpoint-natalizumab-extended-interval-dosing/30124/Optimism vs caution for using extended-interval dosing to prevent progressive multifocal leukoencephalopathy.